The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury

Hepatology

Volumn 48, Issue 3, 2008, Pages 943-952

  Hanada, Shinichiro ^a,b,e   Strnad, Pavel ^a,c   Brunt, Elizabeth M ^d   Omary, M Bishr ^a  

^a STANFORD UNIVERSITY   (United States)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF ULM   (Germany)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Department of Molecular and Integrative Physiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; CYTOKERATIN 18; CYTOKERATIN 8; EOSIN; HEMATOXYLIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTEIN P62; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C3H MOUSE; C57BL 6 MOUSE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CROSS LINKING; GENETIC CORRELATION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIVER CELL; LIVER INJURY; LIVER SIZE; MALE; MALLORY BODY; MALLORY DECK BODY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEATOSIS; STRAIN DIFFERENCE;

ANIMALS; DICARBETHOXYDIHYDROCOLLIDINE; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTES; HYPERTROPHY; INCLUSION BODIES; INTERMEDIATE FILAMENTS; KERATIN-18; KERATIN-8; LIVER; LIVER DISEASES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED STRAINS; UBIQUITIN;

EID: 51349094852     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22436     Document Type: Article

References (37)

1. Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM, et al. From Mallory to Mallory-Denk bodies: What, how and why? Exp Cell Res 2007;313:2033-2049.
2. Ku NO, Strnad P, Zhong BH, Tao GZ, Omary MB. Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies. HEPATOLOGY 2007;46:1639-1649.
3. Goebel HH. Congenital myopathies with inclusion bodies: A brief review. Neuromuscul Disord 1998;8:162-168.
4. Omary MB, Coulombe PA, McLean WH. Intermediate filament proteins and their associated diseases. N Engl J Med 2004;351:2087-2100.
5. Yokoo H, Harwood TR, Racker D, Arak S. Experimental production of Mallory bodies in mice by diet containing 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Gastroenterology 1982;83:109-113.
6. Zatloukal K, Stumptner C, Lehner H, Denk H, Baribault H, Eshkind LG, et al. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determinates the ability of hepatocytes to form Mallory bodies. Am J Pathol 2000; 156:1263-1274.
7. Harada M, Strnad P, Resurreccion EZ, Ku NO, Omary MB. Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. HEPATOLOGY 2007;45:88-96.
8. Magin TM, Schroder R, Leitgeb S, Wanninger K, Zatloukal K, Grund C, et al. Lessons from keratin 18 knockout mice: Formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J Cell Biol 1998; 140:1441-1451.
9. Nakamichi I, Toivola DM, Strnad P, Michie SA, Oshima RG, Baribault H, et al. Keratin 8 overexpression promotes mouse Mallory body formation. J Cell Biol 2005; 171:931-937.
10. Zatloukal K, Fesus L, Denk H, Tarcsa E, Spurej G, Bock G. High amount of epsilon-(gamma-glutamyl) lysine cross-links in Mallory bodies. Lab Invest 1992;66:774-777.
11. Strnad P, Harada M, Siegel M, Terkeltaub RA, Graham RM, Khosla C, et al. Transglutaminase 2 regulates Mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology 2007;132:1515-1526.
12. Harada M, Hanada S, Toivola DM, Ghori N, Omary MB. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation. HEPATOLOGY 2008;47:2026-2035.
13. McPhaul LW, Wang J, Hol EM, Sonnemans MA, Riley N, Nguyen V, et al. Molecular misleading ofthe ubiquitin B gene and hepatic Mallory body formation. Gastroenterology 2002;121/878-1885.
14. Strnad P, Tao GZ, So P, Lau K, Schilling J, Wei Y, et al. 'Toxic memory' via chaperone modification is a potential mechanism for rapid Mallory- Denk body re-induction. HEPATOLOGY 2008; doi Available at: www.hepatology.org.
15. Jensen K, Gluud C. The Mallory body: Morphological, clinical and experimental studies (Part 1 of a literature survey). HEPATOLOGY 1994;20:1061-1077.
16. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
17. Fleming KA, McGee JO. Alcohol induced liver disease. J Clin Pathol 1984;37:721-733.
18. Beck JA, Lloyd S, Hafezparast M, Lennon-Pierce M, Eppig JT, Festing MF, et al. Genealogies of mouse inbred strains. Nat Genet 2000;24:23-25.
19. Petkov PM, Ding Y, Cassell MA, Zhang W, Wagner G, Sargent EE, et al. An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res 2004; 14:1806-1811.
20. Ku NO, Toivola DM, Zhou Q, Tao GZ, Zhong B, Omary MB. Studying simple epithelial keratins in cells and tissues. Methods Cell Biol 2004;8: 489-517.
21. Saxena R, Crawford JM, Navarro VJ, Friedman AL, Robert ME. Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation. Mod Pathol 2002;15:897-903.
22. Small K, Feng JF, Lorenz J, Donnelly ET, Yu A, Im MJ, et al. Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation. J Biol Chem 1999;274:21291-21296.
23. Meierhenry EF, Ruebner BH, Gershwin ME, Hsieh LS, French SW. Dieldrin-induced Mallory bodies in hepatic tumors of mice of different strains. HEPATOLOGY 1983;3:90-95.
24. Harada M, Strnad P, Toivola DM, Omary MB. Autophagy modulates keratin-containing inclusion formation and apoptosis in cell culture in a context-dependent fashion. Exp Cell Res 2008;314:1753-1764.
25. Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 2006;125:443-451.
26. Ambrosini MV, Mariucci G, Tantucci M, Van Hooijdonk L, Ammassari-Teule M. Hippocampal 72-kDa heat shock protein expression varies according to mice learning performance independently from chronic exposure to stress. Hippocampus 2005;15:413-417.
27. Delker DA, Bammler TK, Rosenberg DW. A comparative study of hepatic and colonic metabolic enzymes in inbred mouse lines before and after treatment with the colon carcinogen, 1,2-dimethylhydrazine. Drug Metab Dispos 1996;24:408-413.
28. Löfgren S, Hagbjörk AL, Ekman S, Fransson-Steen R, Terelius Y. Metabolism of human cytochrome P450 marker substrates in mouse: A strain and gender comparison. Xenobiotica 2004;34:811-834.
29. Bardag-Gorce F, Wilson L, Nan L, Li J, French BA, Morgan TR, et al. CYP2E1 inhibition enhances Mallory body formation. Exp Mol Pathol 2005;78:207-211.
30. Stumptner C, Omary MB, Fickert P, Denk H, Zadoukal K. Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a Mallory body mouse model. Am J Pathol 2000; 156:77-90.
31. Fausther M, Villeneuve L, Cadrin M. Heat shock protein 70 expression, keratin phosphorylation and Mallory body formation in hepatocyces from griseofulvin-intoxicated mice. Comp Hepatol 2004;3:5.
32. Denk H, Franke WW, Eckerstorfer R, Schmid E, Kerjaschki D. Formation and involution of Mallory bodies ("alcoholic hyalin") in routine and human liver revealed by immunofluofescence microscopy with antibodies to prekeratin. Proc Nad Acad Sci U S A 1979;76:4112-4116.
33. Yuan QX, Marceau N, French BA, Fu P, French SW. Mallory body induction in drug-primed mouse liver. HEPATOLOGY 1996;24:603-612.
34. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004;431:805-810.
35. Bodner RA, Outeiro TF, Altmann S, Maxwell MM, Cho SH, Hyman BT, et al. Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci U S A 2006;103:4246-4251.
36. Lackner C, Gogg-Kamerer M, Zatloukal K, Stumptner C, Brunt EM, Denk H. Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis. J Hepatol 2008;48:821-828.
37. Katsuma Y, Swierenga SH, Khettry U, Marceau N, French SW. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. HEPATOLOGY 1987;7: 1215-1223.